New options have become available in recent years for the medical management of glaucoma. Drs. Khouri and Sawhney discuss the importance of individualized care for patients, with an emphasis on lowering IOP through enhancing trabecular meshwork outflow using novel therapies rather than surgical options as first-line treatment.
This certified CME/CE activity is designed for specialists and other allied eye care practitioners involved in the management of glaucoma and associated disorders.
Supported by unrestricted educational grants from Aerie Pharmaceuticals and Bausch + Lomb.
At the completion of this educational activity, you will be better able to:
Credit Designation Statement
Evolve Medical Education LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This course is COPE approved for 1.0 hour of CE credit for optometrists.
Sponsored by: State University of New York College of Optometry
Evolve is an approved COPE Administrator.
COPE Course ID: 67918-GL
COPE Event ID: 119353
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Albert S. Khouri, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, and Glaukos. Grant/Research Support: Allergan. Speaker’s Bureau: Aerie, Allergan, and Bausch + Lomb.
Gagan Sawhney, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan and New World Medical.
EDITORIAL SUPPORT DISCLOSURES
The Evolve staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve Medical Education LLC, Aerie Pharmaceuticals, or Bausch + Lomb.